Literature DB >> 22053053

Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua.

John D Fryer1, Peng Yu, Hyojin Kang, Caleigh Mandel-Brehm, Angela N Carter, Juan Crespo-Barreto, Yan Gao, Adriano Flora, Chad Shaw, Harry T Orr, Huda Y Zoghbi.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by expansion of a translated CAG repeat in Ataxin-1 (ATXN1). To determine the long-term effects of exercise, we implemented a mild exercise regimen in a mouse model of SCA1 and found a considerable improvement in survival accompanied by up-regulation of epidermal growth factor and consequential down-regulation of Capicua, which is an ATXN1 interactor. Offspring of Capicua mutant mice bred to SCA1 mice showed significant improvement of all disease phenotypes. Although polyglutamine-expanded Atxn1 caused some loss of Capicua function, further reduction of Capicua levels--either genetically or by exercise--mitigated the disease phenotypes by dampening the toxic gain of function. Thus, exercise might have long-term beneficial effects in other ataxias and neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22053053      PMCID: PMC3232424          DOI: 10.1126/science.1212673

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

1.  Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players.

Authors:  Adriano Chiò; Gianmartino Benzi; Maurizia Dossena; Roberto Mutani; Gabriele Mora
Journal:  Brain       Date:  2005-01-05       Impact factor: 13.501

2.  A MAPK docking site is critical for downregulation of Capicua by Torso and EGFR RTK signaling.

Authors:  Sergio Astigarraga; Rona Grossman; Julieta Díaz-Delfín; Carme Caelles; Ze'ev Paroush; Gerardo Jiménez
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

Review 3.  Exercise builds brain health: key roles of growth factor cascades and inflammation.

Authors:  Carl W Cotman; Nicole C Berchtold; Lori-Ann Christie
Journal:  Trends Neurosci       Date:  2007-08-31       Impact factor: 13.837

4.  ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.

Authors:  Yung C Lam; Aaron B Bowman; Paymaan Jafar-Nejad; Janghoo Lim; Ronald Richman; John D Fryer; Eric D Hyun; Lisa A Duvick; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

5.  Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation.

Authors:  Miho Kawamura-Saito; Yukari Yamazaki; Keiko Kaneko; Noriyoshi Kawaguchi; Hiroaki Kanda; Hiroyuki Mukai; Takahiro Gotoh; Tohru Motoi; Masashi Fukayama; Hiroyuki Aburatani; Toichiro Takizawa; Takuro Nakamura
Journal:  Hum Mol Genet       Date:  2006-05-22       Impact factor: 6.150

Review 6.  Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1.

Authors:  Huda Y Zoghbi; Harry T Orr
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

7.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

Authors:  H T Orr; M Y Chung; S Banfi; T J Kwiatkowski; A Servadio; A L Beaudet; A E McCall; L A Duvick; L P Ranum; H Y Zoghbi
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

8.  Intensive coordinative training improves motor performance in degenerative cerebellar disease.

Authors:  W Ilg; M Synofzik; D Brötz; S Burkard; M A Giese; L Schöls
Journal:  Neurology       Date:  2009-10-28       Impact factor: 9.910

9.  Treadmill training for ataxic patients: a single-subject experimental design.

Authors:  Daniela Virgínia Vaz; Renata de Carvalho Schettino; Teresa Regina Rolla de Castro; Valéria Reis Teixeira; Sheyla Rossana Cavalcanti Furtado; Elyonara de Mello Figueiredo
Journal:  Clin Rehabil       Date:  2007-12-05       Impact factor: 3.477

10.  Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.

Authors:  Janghoo Lim; Juan Crespo-Barreto; Paymaan Jafar-Nejad; Aaron B Bowman; Ronald Richman; David E Hill; Harry T Orr; Huda Y Zoghbi
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

View more
  81 in total

Review 1.  Polyglutamine neurodegeneration: expanded glutamines enhance native functions.

Authors:  Harry T Orr
Journal:  Curr Opin Genet Dev       Date:  2012-01-25       Impact factor: 5.578

Review 2.  Dynamics of DNA methylation in aging and Alzheimer's disease.

Authors:  Hasan A Irier; Peng Jin
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

Review 3.  SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.

Authors:  Harry T Orr
Journal:  Prog Neurobiol       Date:  2012-04-16       Impact factor: 11.685

4.  [Successful aging: what can neurology and geriatrics contribute?].

Authors:  M Synofzik; W Maetzler
Journal:  Nervenarzt       Date:  2015-04       Impact factor: 1.214

Review 5.  Ataxia.

Authors:  Sheng-Han Kuo
Journal:  Continuum (Minneap Minn)       Date:  2019-08

6.  Self-assembling vascular endothelial growth factor nanoparticles improve function in spinocerebellar ataxia type 1.

Authors:  Yuan-Shih Hu; Jeehaeh Do; Chandrakanth Reddy Edamakanti; Ameet R Kini; Marco Martina; Samuel I Stupp; Puneet Opal
Journal:  Brain       Date:  2019-02-01       Impact factor: 13.501

7.  Characterization and Early Detection of Balance Deficits in Fragile X Premutation Carriers With and Without Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS).

Authors:  Joan A O'Keefe; Erin Robertson-Dick; Emily J Dunn; Yan Li; Youping Deng; Amber N Fiutko; Elizabeth Berry-Kravis; Deborah A Hall
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

Review 8.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 9.  Running forward: new frontiers in endurance exercise biology.

Authors:  Glenn C Rowe; Adeel Safdar; Zolt Arany
Journal:  Circulation       Date:  2014-02-18       Impact factor: 29.690

10.  RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1.

Authors:  Megan S Keiser; James C Geoghegan; Ryan L Boudreau; Kim A Lennox; Beverly L Davidson
Journal:  Neurobiol Dis       Date:  2013-04-10       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.